Weisinger discussed findings from the largest cohort of patients with iTTP treated with Obinutuzumab.
Julia Weisinger, MD
Advertisement
PhD candidate at Greater Paris University Hospitals
Articles by Julia Weisinger, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
OMA 2026 Recap: Pediatrics, Retention, and Lifestyle Changes in Obesity
2
OMA 2026 Recap: GLP-1s in Conditions Beyond Obesity
3
OMA 2026 Recap: The Side Effects of GLP-1s for Obesity
4
A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease
5